{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:00:36Z","timestamp":1790859636336,"version":"4.1.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The consequences of serious physical traumatic injury may require pharmacological intervention, however long-term use and polypharmacy can increase risk of morbidity\/mortality. This study aims to describe prescription medication use in a cohort of UK Armed Forces personnel who sustained physical combat injuries during the Afghanistan conflict (injured group) compared to demographically similar personnel without such injuries (uninjured group) a median of 11 years post injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      One thousand and fifty one participants of the ADVANCE cohort (injured group\n                      <jats:italic>n<\/jats:italic>\n                      = 526 uninjured group\n                      <jats:italic>n<\/jats:italic>\n                      = 525), including individuals with (n = 141) and without (\n                      <jats:italic>n<\/jats:italic>\n                      = 384) limb loss or with (n = 226) and without (\n                      <jats:italic>n<\/jats:italic>\n                      = 300) deployment-related Traumatic Brain Injury (TBI), reported medication use during a clinical interview. Overall incidence of prescribing any medication, specific anatomical\/therapeutic classes (e.g., Central Nervous System (CNS), psychotropic or analgesic) and medications with pain or mental health indications were investigated. General (\u22655 medications), CNS (\u22655), psychotropic (\u22652) and analgesic (\u22652) polypharmacy was also investigated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared to the uninjured group, the injured group reported a greater prevalence of prescription medication use (17.8% vs. 29.7%), including medications acting on the CNS (8.0% vs. 17.2%), psychotropics (6.3% vs. 11.8%) and analgesics (2.2% vs. 8.6%). Prevalence of polypharmacy was very low in the cohort (0%\u20134.4%). Incidence Rate Ratios (IRR) and 95% confidence intervals indicated that injured personnel were currently using on average over twice as many prescription medications as those in the uninjured group (IRR 2.15 (1.66, 2.92)), including medications acting on the CNS (IRR 2.67 (1.77, 4.08)), and psychotropics (IRR 2.03 (1.27, 3.25)). Similar elevations were present in those injured with and without limb loss and especially elevated in those with deployment-related TBI. Use of psychotropics amongst personnel injured with limb loss were predominantly for non-mental health indications (e.g., sleep, pain).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pharmacological intervention is not uncommon amongst UK Armed Forces personnel who sustained serious physical injuries, but the prevalence of polypharmacy is low. Effective prescribing practices should ensure optimal recovery whilst minimising the risk of adverse events.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1893711","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:36:03Z","timestamp":1790858163000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Self-reported prescription medication use and polypharmacy following physical combat injury in the UK: the ADVANCE cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Daniel","family":"Dyball","sequence":"first","affiliation":[{"name":"King\u2019s Centre for Military Health Research, King\u2019s College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Grover","sequence":"additional","affiliation":[{"name":"King\u2019s Centre for Military Health Research, King\u2019s College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie","family":"Schofield","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Imperial College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Dixon","family":"Smith","sequence":"additional","affiliation":[{"name":"Pain Research Group, Faculty of Medicine, Imperial College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Kumar","sequence":"additional","affiliation":[{"name":"Academic Department of Military Anaesthesia and Pain Management, Research & Clinical Innovation (RCI)","place":["Birmingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Academic Department of Military Rehabilitation, Defence Medical Rehabilitation Centre","place":["Birmingham, United Kingdom"]},{"name":"Centre for Injury Studies, Department of Bioengineering, Imperial College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Boos","sequence":"additional","affiliation":[{"name":"Faculty of Health & Social Sciences, Bournemouth University","place":["Poole, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M. J.","family":"Bull","sequence":"additional","affiliation":[{"name":"Centre for Injury Studies, Department of Bioengineering, Imperial College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil S. N.","family":"Graham","sequence":"additional","affiliation":[{"name":"Centre for Injury Studies, Department of Bioengineering, Imperial College London","place":["London, United Kingdom"]},{"name":"Department of Brain Sciences, Imperial College London","place":["London, United Kingdom"]},{"name":"UK Dementia Research Institute Centre for Care Research and Technology, Imperial College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl R. Z.","family":"See","sequence":"additional","affiliation":[{"name":"Department of Brain Sciences, Imperial College London","place":["London, United Kingdom"]},{"name":"UK Dementia Research Institute Centre for Care Research and Technology, Imperial College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Orton","sequence":"additional","affiliation":[{"name":"Department of Brain Sciences, Imperial College London","place":["London, United Kingdom"]},{"name":"UK Dementia Research Institute Centre for Care Research and Technology, Imperial College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Blissitt","sequence":"additional","affiliation":[{"name":"Academic Department of Military Rehabilitation, Defence Medical Rehabilitation Centre","place":["Birmingham, United Kingdom"]},{"name":"Department of Brain Sciences, Imperial College London","place":["London, United Kingdom"]},{"name":"UK Dementia Research Institute Centre for Care Research and Technology, Imperial College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Sharp","sequence":"additional","affiliation":[{"name":"Centre for Injury Studies, Department of Bioengineering, Imperial College London","place":["London, United Kingdom"]},{"name":"Department of Brain Sciences, Imperial College London","place":["London, United Kingdom"]},{"name":"UK Dementia Research Institute Centre for Care Research and Technology, Imperial College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola T.","family":"Fear","sequence":"additional","affiliation":[{"name":"King\u2019s Centre for Military Health Research, King\u2019s College London","place":["London, United Kingdom"]},{"name":"Academic Department of Military Mental Health, King\u2019s College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet I.","family":"Kemp","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s11096-016-0371-9","article-title":"Self-reported indications for antidepressant use in a population-based cohort of middle-aged and elderly","volume":"38","author":"Aarts","year":"2016","journal-title":"Int. J. Clin. Pharm."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fpain.2024.1398442","article-title":"Non-opioid psychiatric medications for chronic pain: systematic review and meta-analysis","author":"Ayub","year":"2024","journal-title":"Front. Pain Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/ph12020099","article-title":"Psychotropic drugs for the management of chronic pain and itch","volume":"12","author":"Belinskaia","year":"2019","journal-title":"Pharmaceuticals"},{"key":"B4","doi-asserted-by":"publisher","first-page":"894","DOI":"10.3109\/10826084.2013.796991","article-title":"Opioid and other substance misuse, overdose risk, and the potential for prevention among a sample of OEF\/OIF veterans in New York city","volume":"48","author":"Bennett","year":"2013","journal-title":"Subst. Use and Misuse"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e037850","DOI":"10.1136\/bmjopen-2020-037850","article-title":"Study protocol for a prospective, longitudinal cohort study investigating the medical and psychosocial outcomes of UK combat casualties from the Afghanistan war: the ADVANCE study","volume":"10","author":"Bennett","year":"2020","journal-title":"BMJ Open"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/mkrt2948","article-title":"Antidepressants for pain management in adults with chronic pain: a network meta-analysis","volume":"28","author":"Birkinshaw","year":"2024","journal-title":"Health Technol. Assess."},{"key":"B7","volume-title":"Cognitive and Functional Outcomes a Decade After Military Traumatic Brain Injury: The ADVANCE Cohort Study","author":"Blissett","year":"2026"},{"key":"B8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/MLR.0b013e318202aa27","article-title":"Accidental poisoning mortality among patients in the department of veterans affairs health system","volume":"49","author":"Bohnert","year":"2011","journal-title":"Med. Care"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/pmrj.12526","article-title":"Accumulation of good intentions: how individual practice guidelines lead to polypharmacy in the treatment of patients with polytrauma","volume":"13","author":"Brown-Taylor","year":"2021","journal-title":"PM&R"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.1038\/s41467-023-40637-8","article-title":"Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend study","volume":"14","author":"Chan","year":"2023","journal-title":"Nat. Commun."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008943.pub2","article-title":"Combination pharmacotherapy for the treatment of neuropathic pain in adults","author":"Chaparro","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40801-015-0055-0","article-title":"Prevalence of central nervous system polypharmacy and associations with overdose and suicide-related behaviors in Iraq and Afghanistan war veterans in VA care 2010\u20132011","volume":"3","author":"Collett","year":"2016","journal-title":"Drugs - Real World Outcomes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/01.HTR.0000300227.67748.77","article-title":"Initial reliability and validity of the Ohio state university TBI identification method","volume":"22","author":"Corrigan","year":"2007","journal-title":"J. Head Trauma Rehabilitation"},{"key":"B14","first-page":"E941","article-title":"Current understanding of phantom pain and its treatment","volume":"25","author":"Culp","year":"2022","journal-title":"Pain Physician"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fpain.2025.1512878","article-title":"Unpacking excessive polypharmacy patterns among individuals living with chronic pain in Quebec: a longitudinal study","author":"De Clifford-Faug\u00e8re","year":"2025","journal-title":"Front. Pain Res."},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.6580845","article-title":"Visible and invisible injuries of war: the long-term psychosocial outcomes of physical combat injuries, limb loss and traumatic brain injury: ADVANCE cohort study","volume-title":"Limb Loss and Traumatic Brain Injury: ADVANCE Cohort Study","author":"Dyball","year":"2026"},{"key":"B17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/s2215-0366(22)00112-2","article-title":"Mental health outcomes of Male UK military personnel deployed to Afghanistan and the role of combat injury: analysis of baseline data from the ADVANCE cohort study","volume":"9","author":"Dyball","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1007\/s10654-025-01300-2","article-title":"Evaluating the physical and psychosocial impact of serious physical combat injuries in UK armed forces personnel-the ADVANCE cohort study","author":"Dyball","year":"2025","journal-title":"Eur. J. Epidemiol"},{"key":"B19","first-page":"2","article-title":"Polypharmacy involving opioid, psychotropic, and central nervous system depressant medications, period prevalence and association with suicidal ideation, active component, U.S. armed forces, 2016","volume":"25","author":"Eide","year":"2018","journal-title":"Msmr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","article-title":"Updating the beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts","volume":"163","author":"Fick","year":"2003","journal-title":"Archives Intern. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jad.2006.07.003","article-title":"Indications for antidepressant drug prescribing in general practice in the Netherlands","volume":"98","author":"Gardarsdottir","year":"2007","journal-title":"J. Affect. Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.3390\/healthcare13172122","article-title":"Psychotropic medications for non-psychiatric conditions: a narrative review","volume":"13","author":"Gentry","year":"2025","journal-title":"Healthcare"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1097\/j.pain.0000000000002313","article-title":"Opioid prescribing in the US military health system, 2014 to 2018: fewer prescriptions, fewer pills, and shorter treatment duration","volume":"163","author":"Goldman","year":"2022","journal-title":"Pain"},{"key":"B24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMp1704633","article-title":"Gabapentin and pregabalin for pain - is increased prescribing a cause for concern?","volume":"377","author":"Goodman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1007\/s11606-024-08817-4","article-title":"Contribution of potentially inappropriate medications to polypharmacy-associated risk of mortality in middle-aged patients: a national cohort study","volume":"39","author":"Guillot","year":"2024","journal-title":"J. General Intern. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1037\/0002-9432.75.1.3","article-title":"Socioeconomic status and mental illness: tests of the social causation and selection hypotheses","volume":"75","author":"Hudson","year":"2005","journal-title":"Am. Journal Orthopsychiatry"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1097\/JOM.0000000000001872","article-title":"A time-series analysis of the association between occupational health policies and opioid prescription patterns in United States active duty military service members from 2006 to 2018","volume":"62","author":"Jannace","year":"2020","journal-title":"J. Occupational Environmental Medicine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1111\/bcp.15352","article-title":"Fatalities associated with gabapentinoids in England (2004\u20132020)","volume":"88","author":"Kalk","year":"2022","journal-title":"Br. Journal Clinical Pharmacology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.addbeh.2018.12.007","article-title":"Opioid and sedative misuse among veterans wounded in combat","volume":"92","author":"Kelley","year":"2019","journal-title":"Addict. Behav."},{"key":"B30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.pmn.2024.03.008","article-title":"A systematic review of chronic pain management interventions among veterans of recent wars and armed conflicts","volume":"25","author":"Lakshman","year":"2024","journal-title":"Pain Manag. Nurs."},{"key":"B31","doi-asserted-by":"publisher","first-page":"104630","DOI":"10.1016\/j.archger.2022.104630","article-title":"Association between polypharmacy and mortality in the older adults: a systematic review and meta-analysis","volume":"100","author":"Li","year":"2022","journal-title":"Archives Gerontology Geriatrics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1089\/neu.2006.0245","article-title":"The Mayo classification system for traumatic brain injury severity","volume":"24","author":"Malec","year":"2007","journal-title":"J. Neurotrauma"},{"key":"B33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1136\/jramc-2017-000892","article-title":"From northern Ireland to Afghanistan: half a century of blast injuries","volume":"165","author":"McGuire","year":"2019","journal-title":"J. R. Army Med. Corps"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1091","DOI":"10.1093\/milmed\/usaa038","article-title":"Outpatient pharmacy prescriptions during the first year following serious combat injury: a retrospective analysis","volume":"185","author":"Melcer","year":"2020","journal-title":"Mil. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40801-022-00298-3","article-title":"Polypharmacy in Australian veterans with post-traumatic stress disorder upon admission to a mental health facility: a retrospective chart review","volume":"9","author":"Mellor","year":"2022","journal-title":"Drugs - Real World Outcomes"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1097\/j.pain.0000000000003239","article-title":"Risk of adverse outcomes during gabapentinoid therapy and factors associated with increased risk in UK primary care using the clinical practice research datalink: a cohort study","volume":"165","author":"Muller","year":"2024","journal-title":"Pain"},{"key":"B38","year":"2025","journal-title":"Chronic Pain"},{"key":"B39","year":"2016","journal-title":"Health Surv. Engl"},{"key":"B40","unstructured":"Advice for prescribers on the risk of the misuse of pregabalin and gabapentin 2014"},{"key":"B41","unstructured":"Prescribed medicines review: summary 2020"},{"key":"B42","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jad.2024.10.025","article-title":"Prevalence and factors associated with polypharmacy in military and veteran populations: a systematic review and meta-analysis","volume":"369","author":"Raut","year":"2025","journal-title":"J. Affect. Disord."},{"key":"B43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/jcp.0000000000001400","article-title":"The pitfalls of psychotropic polypharmacy","volume":"41","author":"Rothschild","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fpsyt.2021.643609","article-title":"Comorbid chronic pain and depression: shared risk factors and differential antidepressant effectiveness","author":"Roughan","year":"2021","journal-title":"Front. Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s11606-020-06258-3","article-title":"Opioid prescribing and opioid risk mitigation strategies in the veterans health administration","volume":"35","author":"Sandbrink","year":"2020","journal-title":"J. General Intern. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3389\/fphar.2019.00994","article-title":"Polypharmacy and nutraceuticals in veterans: pros and cons","volume":"10","author":"Sciarra","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2147\/CLEP.S163037","article-title":"Concordance assessment of self-reported medication use in the Netherlands three-generation lifelines cohort study with the pharmacy database iaDB.nl: the PharmLines initiative","volume":"10","author":"Sediq","year":"2018","journal-title":"Clin. Epidemiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/s1474-4422(25)00068-7","article-title":"Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis","volume":"24","author":"Soliman","year":"2025","journal-title":"Lancet Neurology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.pnpbp.2018.07.017","article-title":"Overlaps in pharmacology for the treatment of chronic pain and mental health disorders","volume":"87","author":"Sutherland","year":"2018","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"B50","first-page":"34","article-title":"Psychotropic polypharmacy in Australian Vietnam war veterans with post-traumatic stress disorder: a descriptive cohort study","volume":"28","author":"Theal","year":"2020","journal-title":"J. Mil. Veterans Health"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e1019","DOI":"10.4088\/JCP.16m10671","article-title":"Paradoxical trend for improvement in mental health with aging: a community-based study of 1,546 adults aged 21-100 years","volume":"77","author":"Thomas","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1001\/jamainternmed.2014.2726","article-title":"Chronic pain and opioid use in US soldiers after combat deployment","volume":"174","author":"Toblin","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bja.2020.05.017","article-title":"Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland","volume":"125","author":"Torrance","year":"2020","journal-title":"Br. J. Anaesth."},{"key":"B54","unstructured":"Control of pregabalin and gabapentin under the misuse of drugs act 1971 2019"},{"key":"B55","volume-title":"Querying State Prescription Drug Monitoring Programs (PDMP): VHA DIRECTIVE","year":"2024"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.bja.2024.02.019","article-title":"Pain after combat injury in Male UK military personnel deployed to Afghanistan","volume":"132","author":"Vollert","year":"2024","journal-title":"Br. J. Anaesth."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.drugpo.2014.07.009","article-title":"Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons","volume":"25","author":"Weisberg","year":"2014","journal-title":"Int. J. Drug Policy"},{"key":"B58","volume-title":"ATC Classification Index with Ddds 2020","year":"2020"},{"key":"B59","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/jramc-145-03-07","article-title":"A method of assigning socio-economic status classification to British armed forces personnel","volume":"145","author":"Yoong","year":"1999","journal-title":"J. R. Army Med. Corps."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.2147\/jpr.s411451","article-title":"Polypharmacy and excessive polypharmacy among persons living with chronic pain: a cross-sectional study on the prevalence and associated factors","volume":"16","author":"Zahlan","year":"2023","journal-title":"J. Pain Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1893711\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:36:06Z","timestamp":1790858166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1893711\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":60,"alternative-id":["10.3389\/fphar.2026.1893711"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1893711","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"1893711"}}